Skip to content

Veracyte VCYT Shares (Diluted)

Shares (Diluted) at other companies

Guardant Health logo
Guardant HealthGH
131.3M+6.0%
Natera, Inc. logo
Natera, Inc.NTRA
141.5M+5.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
27M-3.6%
Agilent Technologies logo
Agilent TechnologiesA
283M-0.7%
Revvity logo
RevvityRVTY
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's shares (diluted)?
Veracyte (VCYT) reported shares (diluted) of 81.3M in Q1 2026.
How has Veracyte's shares (diluted) changed year-over-year?
Veracyte's shares (diluted) increased by 1.6% year-over-year, from 80.1M to 81.3M.
What is the long-term trend for Veracyte's shares (diluted)?
Over 4 years (2021 to 2025), Veracyte's shares (diluted) has grown at a 4.4% compound annual growth rate (CAGR), from 268.3M to 318.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.